[HTML][HTML] Fibroblast growth factor 23—Klotho and hypertension: Experimental and clinical mechanisms
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms
M Freundlich, G Gamba, B Rodriguez-Iturbe - Pediatric Nephrology, 2020 - hero.epa.gov
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms.
M Freundlich, G Gamba, B Rodriguez-Iturbe - Pediatric Nephrology, 2021 - go.gale.com
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms.
M Freundlich, G Gamba… - Pediatric Nephrology …, 2020 - europepmc.org
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
[HTML][HTML] Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
M Freundlich, G Gamba… - Pediatric Nephrology …, 2021 - ncbi.nlm.nih.gov
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
[PDF][PDF] Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
M Freundlich, G Gamba, B Rodriguez-Iturbe - Pediatric Nephrology, 2021 - academia.edu
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms.
M Freundlich, G Gamba… - Pediatric …, 2021 - search.ebscohost.com
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms
M Freundlich, G Gamba… - Pediatric nephrology …, 2021 - pubmed.ncbi.nlm.nih.gov
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
M Freundlich, G Gamba… - Pediatric nephrology …, 2020 - scholarship.miami.edu
Hypertension (HTN) and chronic kidney disease (CKD) are increasingly recognized in
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …
pediatric patients and represent risk factors for cardiovascular morbidity and mortality later in …